Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-22 4:15 pm Sale |
2023-08-11 | 13D | Chinook Therapeutics, Inc. KDNY |
Samsara BioCapital, L.P. | 0 0.000% |
-5,181,557 (Position Closed) |
Filing History |
| 2023-08-11 5:17 pm Purchase |
2023-08-02 | 13D | Chinook Therapeutics, Inc. KDNY |
FARALLON CAPITAL PARTNERS LP | 7,110,000 9.900% |
7,110,000 (New Position) |
Filing History |
| 2023-08-01 08:56 am Purchase |
2020-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
BAILLIE GIFFORD & CO | 844,684 2.000% |
844,684 (New Position) |
Filing History |
| 2023-03-10 4:13 pm Sale |
2023-03-01 | 13D | Chinook Therapeutics, Inc. KDNY |
Versant Venture Capital VII L.P. | 2,105,107 3.200% |
-240,000 (-10.23%) |
Filing History |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Point72 Asset Management, L.P. | 1,299,548 2.000% |
-1,817,932 (-58.31%) |
Filing History |
| 2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Frazier Life Sciences Public Fund, L.P. | 4,052,510 6.300% |
1,282,484 (+46.30%) |
Filing History |
| 2023-02-14 08:42 am Purchase |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Deep Track Capital, LP | 3,000,000 4.690% |
247,930 (+9.01%) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
BLACKROCK INC BLK |
3,954,741 6.200% |
966,810 (+32.36%) |
Filing History |
| 2022-12-28 4:07 pm Sale |
2022-12-22 | 13D | Chinook Therapeutics, Inc. KDNY |
Versant Venture Capital VII L.P. | 2,345,107 3.700% |
-567,963 (-19.50%) |
Filing History |
| 2022-08-22 4:15 pm Unchanged |
2022-08-12 | 13D | Chinook Therapeutics, Inc. KDNY |
Versant Venture Capital VII L.P. | 2,913,070 4.600% |
0 (Unchanged) |
Filing History |
| 2022-06-07 4:45 pm Purchase |
2022-05-27 | 13G | Chinook Therapeutics, Inc. KDNY |
Point72 Asset Management, L.P. | 3,117,480 5.100% |
3,117,480 (New Position) |
Filing History |
| 2022-06-01 4:00 pm Purchase |
2020-10-05 | 13D | Chinook Therapeutics, Inc. KDNY |
Samsara BioCapital, L.P. | 5,181,557 8.400% |
5,181,557 (New Position) |
Filing History |
| 2022-04-29 12:19 pm Purchase |
2022-04-21 | 13G | Chinook Therapeutics, Inc. KDNY |
Frazier Life Sciences Public Fund, L.P. | 2,770,026 5.000% |
2,770,026 (New Position) |
Filing History |
| 2022-04-13 4:43 pm Sale |
2022-04-04 | 13D | Chinook Therapeutics, Inc. KDNY |
Versant Venture Capital VII L.P. | 2,913,070 5.300% |
-709,953 (-19.60%) |
Filing History |
| 2022-02-22 06:13 am Sale |
2021-08-16 | 13D | ADURO BIOTECH, INC ADRO |
Morningside Venture (VI) Investments Ltd | 15,078 0.030% |
-2,969,527 (-99.49%) |
Filing History |
| 2022-02-16 4:46 pm Purchase |
2022-02-14 | 13G | Chinook Therapeutics, Inc. KDNY |
Deep Track Capital, LP | 2,752,070 5.040% |
2,752,070 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
BLACKROCK INC BLK |
2,987,931 5.600% |
2,987,931 (New Position) |
Filing History |
| 2022-01-21 4:01 pm Sale |
2021-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
ATP Life Science Ventures L.P. | 0 0.000% |
-4,028,937 (Position Closed) |
Filing History |
| 2022-01-13 4:30 pm Sale |
2022-01-03 | 13D | Chinook Therapeutics, Inc. KDNY |
Versant Venture Capital VII L.P. | 3,623,023 6.700% |
-600,000 (-14.21%) |
Filing History |
| 2021-09-07 5:13 pm Sale |
2021-08-27 | 13D | Chinook Therapeutics, Inc. KDNY |
Versant Venture Capital VII L.P. | 4,223,023 9.400% |
-510,000 (-10.78%) |
Filing History |